ReviewEchocardiography (Mount Kisco, N.Y.)2026
Clinical Applications of Right Ventricular Strain by Two-Dimensional Speckle-Tracking Echocardiography.
Review in Echocardiography (Mount Kisco, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Applications of Right Ventricular Strain by Two-Dimensional Speckle-Tracking Echocardiography.Echocardiography (Mount Kisco, N.Y.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Assessment of right ventricular (RV) function by two-dimensional (2D) echocardiography remains challenging due to complex geometry, limited acoustic windows, and the angle dependency of conventional parameters. RV longitudinal strain, derived from 2D speckle-tracking echocardiography, has emerged as a quantitative, angle-independent marker of myocardial deformation, enabling earlier detection of dysfunction and providing incremental diagnostic and prognostic value beyond traditional indices in selected settings. RV free-wall longitudinal strain is most commonly used in clinical practice, with established reference values and growing applicability across a broad spectrum of cardiovascular and pulmonary diseases, including pulmonary hypertension, heart failure, ischemic heart disease, cardiomyopathies, and valvular heart disease. However, despite growing evidence supporting its clinical utility, its integration into routine decision-making remains limited. Important constraints persist, particularly inter-vendor variability and relatively high test-retest variability, which affect reproducibility and limit standardization. Emerging techniques, including three-dimensional strain, and artificial intelligence-based analysis, once sufficiently validated and standardized, hold potential to improve measurement accuracy and reproducibility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.